OBJECTIVE: To explore the relationship between several indicators of depression and metabolic syndrome (MetS). METHOD: A population-based sample with high (HMS group) or low (LMS group) levels of mental symptoms, including those of depression, in three follow-ups participated in a clinical examination in 2005 (n = 223). MetS was determined according to the NCEP criteria. RESULTS: The prevalence of MetS was 49% in men and 21% in women. Men with MetS had higher rates of major depressive disorder than other men. They also displayed higher Hamilton Rating Scale for Depression (HDRS) scores and more often signs of suicidality. In logistic regression analyses, higher HDRS scores (OR 1.31, 95% CI 1.04-1.64) and belonging to the HMS group (OR 10.1, 95% CI 1.98-51.3) were independent associates for MetS but only in men. CONCLUSION: The results highlight that there is an association between long-term depressive symptoms and the emergence of MetS, especially in men.
OBJECTIVE: To explore the relationship between several indicators of depression and metabolic syndrome (MetS). METHOD: A population-based sample with high (HMS group) or low (LMS group) levels of mental symptoms, including those of depression, in three follow-ups participated in a clinical examination in 2005 (n = 223). MetS was determined according to the NCEP criteria. RESULTS: The prevalence of MetS was 49% in men and 21% in women. Men with MetS had higher rates of major depressive disorder than other men. They also displayed higher Hamilton Rating Scale for Depression (HDRS) scores and more often signs of suicidality. In logistic regression analyses, higher HDRS scores (OR 1.31, 95% CI 1.04-1.64) and belonging to the HMS group (OR 10.1, 95% CI 1.98-51.3) were independent associates for MetS but only in men. CONCLUSION: The results highlight that there is an association between long-term depressive symptoms and the emergence of MetS, especially in men.
Authors: Nicole Vogelzangs; Aartjan T F Beekman; Arianne K B van Reedt Dortland; Robert A Schoevers; Erik J Giltay; Peter de Jonge; Brenda W J H Penninx Journal: Neuropsychopharmacology Date: 2014-01-20 Impact factor: 7.853
Authors: Nicole Vogelzangs; Aartjan T F Beekman; Ingrid G Boelhouwer; Stefania Bandinelli; Yuri Milaneschi; Luigi Ferrucci; Brenda W J H Penninx Journal: J Clin Psychiatry Date: 2011-04-05 Impact factor: 4.384
Authors: Anne Huotari; Soili M Lehto; Leo Niskanen; Karl-Heinz Herzig; Jukka Hintikka; Heli Koivumaa-Honkanen; Tommi Tolmunen; Kirsi Honkalampi; Noora Kaikkonen; Heimo Viinamäki Journal: Cardiovasc Psychiatry Neurol Date: 2010-03-14
Authors: Meiwen Zhang; Hilary C Tanenbaum; Jamie Q Felicitas-Perkins; Zengchang Pang; Paula H Palmer; Haiping Duan; C Anderson Johnson; Bin Xie Journal: Psychol Health Med Date: 2016-06-03 Impact factor: 2.423
Authors: Teemu Rissanen; Heimo Viinamäki; Kirsi Honkalampi; Soili M Lehto; Jukka Hintikka; Tarja Saharinen; Heli Koivumaa-Honkanen Journal: BMC Psychiatry Date: 2011-08-23 Impact factor: 3.630
Authors: Antti-Pekka Elomaa; Leo Niskanen; Karl-Heinz Herzig; Heimo Viinamäki; Jukka Hintikka; Heli Koivumaa-Honkanen; Kirsi Honkalampi; Minna Valkonen-Korhonen; Ilkka T Harvima; Soili M Lehto Journal: BMC Psychiatry Date: 2012-01-09 Impact factor: 3.630